Ignite Creation Date:
2025-12-25 @ 3:07 AM
Ignite Modification Date:
2026-01-09 @ 1:07 PM
Study NCT ID:
NCT04948333
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-23
First Post:
2021-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Asciminib Treatment Optimization in ≥ 3rd Line CML-CP
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-13
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-02-03
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-28
First Submit QC Date:
None
Study First Post Date:
2021-07-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-03-11
Results First Submit QC Date:
None
Results First Post Date:
2025-03-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED